BHC (Bausch Health) Defensive Interval Ratio


BHC Bausch Health Companies Inc BHC
58 GF Score
Price $4.83
GF Value $7.92
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Bausch Health Defensive Interval Ratio?

BHC
58GF Score
Bausch Health Companies Inc BHC
Defensive Interval Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Bausch Health (BHC) Overvalued in 2026?

Based on GuruFocus' analysis, Bausch Health stock appears to be undervalued. The current stock price of $4.83 is trading 39.1% below its estimated GF Value™ of $7.92. GuruFocus considers Bausch Health to be Possible Value Trap.

Key valuation signals for BHC:

  • Defensive Interval Ratio:
  • GF Value™: $7.92 vs. price of $4.83 (39.1% below fair value)
  • GF Score™: 58/100 with 3 warning signs

No single metric tells the full story. See the BHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bausch Health Business Description

Address 2150 St Elzear Boulvard West, Laval, QC, CAN, H7L 4A8
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.
58GF Score

Get the complete analysis for BHC

Defensive Interval Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.83
Price
$7.92
GF Value